RNS Number : 7613L
BlackRock Group
08 July 2014
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Nameofpersondealing(Note1)

BlackRock, Inc.

Companydealtin

Kenmare Resources Plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)

€0.06 ordinary

Dateofdealing

07 July 2014

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities

230,421,531 (8.28%)

0 (0.00%)

(2)Derivatives(otherthanoptions)

12,000,000 (0.43%)

3,181,650 (0.11%)

(3)Optionsandagreementstopurchase/sell

0 (0.00%)

Total

242,421,531 (8.71%)

3,181,650 (0.11%)

 

(b)        Interests and short positions in relevant securitiesof the company, other than the class dealt in (Note 3)

Classofrelevantsecurity:

Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities



 

(2)Derivatives(otherthanoptions)



 

(3)Optionsandagreementstopurchase/sell



Total



 



 

Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit(Note5)




 

Please note: there was a Transfer In of 135,422 Shares

 

(b)      Derivatives transactions (other than options transactions)

 

Productname,

e.g.CFD

Natureoftransaction

(Note6)

Numberofrelevantsecurities

(Note7)

Priceperunit

(Note5)

 

CFD

 

Reducing Short

 

141,817

 

GBP 0.1600

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing,selling, purchasing or varying

 

Productname,

e.g.calloption

Writing,selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates(Note7)

Exercise price

Type,e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit(Note5)








 

(ii)      Exercising

 

Productname,

e.g.calloption

Numberofsecurities

Exercisepriceper unit(Note5)




 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Natureoftransaction

(Note8)

Details

Priceperunit

(if applicable) (Note 5)





Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full detailsof any agreement, arrangement or understanding betweenthe person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevantsecurities to which any derivativereferred to on this form is referenced. If none, this should be stated.

 

 

 

                                                            None

 

 

 

 

 

 

Is a Supplemental Form 8 attached?(Note 9)                                            YES

 

Dateofdisclosure

08 July 2014

Contactname

Duncan Murray

Telephonenumber

020 7743 3334

IfaconnectedEFM,nameofofferee/offerorwithwhichconnected


IfaconnectedEFM,statenatureofconnection(Note10)


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i),Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS(Note 1)

 

 

 

Productname,

e.g.calloption

Written,orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price(Note2)

Type,e.g.American,Europeanetc.

Expiry date

Warrant

N/A

12,000,000

 GBP 0.29

N/A

16/11/2019

 

 

Notes

 

1.          Where there are open option positionsor open derivative positions (except for CFDs), full details should be given. Full detailsof any existing agreements to purchase or to sell must also be given on this form.

 

2.          For all prices and other monetaryamounts, the currencymust be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consultthe Panel.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEZMGGNFRFGDZM